The market expects Editas Medicine (EDIT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus ...
A Swedish scientist is believed to be the first in the world to attempt to edit DNA in healthy human embryos, according to an exclusive report from NPR. The practice is controversial and has been ...
A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 17% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 16.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback